Issuance of Stock Options (Stock Acquisition Rights)
First written in FY2017-Q2. 9 of 22 entries say "Restated". Latest entry: FY2025-H1.
- FY2025-H1RestatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The interim report also states that there were no applicable matters concerning stock options or other stock acquisition rights. - FY2024RestatedAnnual report
「① [Details of the stock option scheme] There are no applicable matters. ③ [Status of other stock acquisition rights, etc.] There are no applicable matters.」
The company also states that there were no applicable matters concerning stock options or other stock acquisition rights during the fiscal year. - FY2024-Q3RestatedAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The third-quarter report also states that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2024-Q1RestatedAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The first-quarter report also states that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2023-Q3RestatedAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The third-quarter report also states that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2023-Q2RestatedAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The second-quarter report also states that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2023-Q1RestatedAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The first-quarter report states that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2022-Q1Recognition of gain on reversal of stock acquisition rights in the first quarter; no issuanceAnnual report
「Gain on reversal of stock acquisition rights 20,548」
The company recorded a gain on reversal of stock acquisition rights of ¥20.548 million as extraordinary income in the first quarter and stated that there were no applicable matters concerning the stock option scheme or the issuance of other stock acquisition rights. - FY2021AdvancedAnnual report
「Exercised — 55,600" Lapsed 175,000 2,000" Outstanding and unexercised — 373,600」
During the year, 55,600 shares under the 2016 stock option plan were exercised, 2,000 shares lapsed, and 373,600 shares remained outstanding and unexercised. - FY2021-Q3Third-quarter gain on reversal of stock acquisition rights recognizedAnnual report
「Gain on reversal of stock acquisition rights 13,368" The stock acquisition rights issued during the third quarter accounting period are as follows." —」
A gain on reversal of stock acquisition rights of ¥13.368 million was recognized for the nine months ended the third quarter, and no stock acquisition rights were issued during the third quarter accounting period. - FY2021-Q2No stock acquisition rights issued in the first halfAnnual report
「① [Details of the stock option plan] No applicable matters." ② [Status of other stock acquisition rights, etc.] No applicable matters.」
The report for the second quarter states that there were no applicable matters concerning the issuance of stock acquisition rights or the stock option plan. - FY2021-Q1Quarterly gain on reversal of stock acquisition rights recognizedAnnual report
「Gain on reversal of stock acquisition rights 22」
A gain on reversal of stock acquisition rights of ¥22 thousand was recognized as an extraordinary gain in the first quarter. No stock acquisition rights were issued during the quarter. - FY2020Full-year gain on reversal of stock acquisition rights recognizedAnnual report
「Gain on reversal of stock acquisition rights 41,589」
A gain on reversal of stock acquisition rights of ¥41.589 million was recognized as an extraordinary gain for the current consolidated fiscal year. No new shares were issued during the year. - FY2020-Q3Third-quarter gain on reversal of stock acquisition rights updateAnnual report
「Gain on reversal of stock acquisition rights 41,567」
A gain on reversal of stock acquisition rights of ¥41.567 million was recognized for the nine months ended the third quarter. There was no increase in shares issued and no issuance of stock acquisition rights during the third quarter accounting period. - FY2020-Q2Recognition of gains from the reversal of stock option liabilitiesAnnual report
「Gain on reversal of stock acquisition rights 41,518」
A gain on reversal of stock acquisition rights of ¥41.518 million was recognized as an extraordinary gain for the six months ended the second quarter. - FY2020-Q1Recognition of gains from the reversal of stock option liabilitiesAnnual report
「Gain on reversal of stock acquisition rights 41,411」
A gain on reversal of stock acquisition rights of ¥41.411 million was recognized as an extraordinary gain in the first quarter. - FY2019AdvancedAnnual report
「The 49,640-share increase in shares issued during the current consolidated fiscal year was due to the exercise of stock acquisition rights.」
During the year, the exercise of stock acquisition rights increased the number of shares by 49,640, and increased share capital and capital surplus by ¥16.463 million each. - FY2019-Q2AdvancedAnnual report
「1 August 2018–31 October 2018" 49,640" Increase due to the exercise of stock acquisition rights.」
During the quarter, the exercise of stock acquisition rights increased the number of shares by 49,640, and increased share capital and capital surplus by ¥16.463 million each. - FY2018RestatedAnnual report
「1 May 2017–30 April 2018" 42,820" Increase due to the exercise of stock acquisition rights.」
The full-year disclosure also confirms a 42,820-share increase in shares issued due to the exercise of stock acquisition rights. - FY2018-Q2AdvancedAnnual report
「1 August 2017–31 October 2017" 42,820" 6,431,560" 14,430" 708,289" 14,430" 846,806" Increase due to the exercise of stock acquisition rights.」
During the quarter, the exercise of stock acquisition rights increased the number of shares by 42,820, resulting in increases in total shares issued, share capital, and capital surplus. - FY2017RestatedAnnual report
「Resolution of the Board of Directors dated 15 August 2016」
The annual report confirms the issuance and outstanding status of stock acquisition rights covering 499,700 shares under the 2016 stock option plan. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows." Number of stock acquisition rights (units): 4,997" Number of underlying shares (shares): 499,700" Exercise price (¥): 569" Exercise period: 16 August 2018 to 31 July 2021」
The company disclosed the issuance during the quarter of stock acquisition rights covering 4,997 units and 499,700 shares, together with the exercise conditions.